Search - tctmd.com

Displaying 301 - 320 of 1700

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Industry News

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

May 23, 2019

News Conference News EuroPCR 2019

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Caitlin E. Cox

May 23, 2019

News Conference News EuroPCR 2019

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

L.A. McKeown

May 22, 2019

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

L.A. McKeown

May 22, 2019

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Caitlin E. Cox

May 10, 2019

News Industry News

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

May 07, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Industry News

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

May 06, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

Presentation ARCH 2019

Femoral Access-Basics

Presenter: Howard Kurz

April 10, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

Shelley Wood

March 29, 2019

Presentation SIF 2019

Thrombosis and No-Reflow

Presenter: Sripal Bangalore

March 29, 2019

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Conference News ACC 2019

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Yael L. Maxwell

March 18, 2019

Advertisement

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

Update: Drug-Eluting Stents

Femoral Access-Basics

TCTMD’s Top 10 Most Popular Stories for March 2019

Thrombosis and No-Reflow

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content